Profound Medical Corp. 8-K

What Happened
Profound Medical Corp. (PROF) filed a Form 8-K on March 9, 2026 (Regulation FD disclosure) announcing an investor conference call to discuss clinical outcomes from the Company’s CAPTAIN trial. The press release announcing the call was furnished as Exhibit 99.1 to the 8-K.

Key Details

• Conference call scheduled for March 13, 2026 at 11:30 a.m. ET to discuss CAPTAIN trial clinical outcomes.
• Press release announcing the call dated March 9, 2026 (Exhibit 99.1) includes the advanced registration link and call access instructions.
• The Form 8-K was signed and filed March 9, 2026 by Chief Financial Officer Rashed Dewan.
• Disclosure reported under Item 7.01 (Regulation FD); an Inline XBRL cover page is included as Exhibit 104.

Why It Matters
This announcement signals that the company will publicly discuss clinical data from the CAPTAIN trial—information that can affect investor views on clinical progress, regulatory prospects, and future commercial potential. The Regulation FD filing and furnished press release ensure the details and call access are broadly available to investors and the public.